Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
BS Graham - Immunological reviews, 2011 - Wiley Online Library
Respiratory syncytial virus (RSV) is an important cause of respiratory disease causing high
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
[HTML][HTML] Biological Challenges and Technological Opportunities for Respiratory Syncytial Virus Vaccine Development
BS Graham - Immunological reviews, 2011 - ncbi.nlm.nih.gov
Respiratory syncytial virus (RSV) is an important cause of respiratory disease causing high
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.
BS Graham - Immunological Reviews, 2011 - search.ebscohost.com
Respiratory syncytial virus (RSV) is an important cause of respiratory disease causing high
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.
BS Graham - Immunological Reviews, 2011 - europepmc.org
Respiratory syncytial virus (RSV) is an important cause of respiratory disease causing high
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
[引用][C] Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
BS GRAHAM - Immunological reviews, 2011 - pascal-francis.inist.fr
Biological challenges and technological opportunities for respiratory syncytial virus vaccine
development CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
development CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
BS Graham - Immunological Reviews, 2010 - infona.pl
Respiratory syncytial virus (RSV) is an important cause of respiratory disease causing high
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
BS Graham - Immunological Reviews, 2010 - cir.nii.ac.jp
抄録< jats: p>< jats: bold> Summary:</jats: bold> Respiratory syncytial virus (RSV) is an
important cause of respiratory disease causing high rates of hospitalizations in infants …
important cause of respiratory disease causing high rates of hospitalizations in infants …
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
BS Graham - Immunological reviews, 2011 - pubmed.ncbi.nlm.nih.gov
Respiratory syncytial virus (RSV) is an important cause of respiratory disease causing high
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.
BS Graham - Immunological Reviews, 2011 - europepmc.org
Respiratory syncytial virus (RSV) is an important cause of respiratory disease causing high
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …
rates of hospitalizations in infants, significant morbidity in children and adults, and excess …